Smokers Who Quit Before Age 45 Significantly Reduce Risk of Lung Cancer

Industry Insight by VapingPost
Jun.09.2022
Smokers Who Quit Before Age 45 Significantly Reduce Risk of Lung Cancer
A new study conducted by the American Cancer Society highlighted that while quitting smoking reduces cancer risks at any age, doing so before the age of 45 nearly eliminates all risk.

Titled, “Association of Smoking Initiation and Cessation Across the Life Course and Cancer Mortality Prospective Study of 410 000 US Adults,” the study of over 400,000 Americans, found that smokers are three times more likely to die of a tobacco-related cancer than nonsmokers.

 

However, reported the researchers, quitting by age 45 reduces this risk by 89%, while for those who quit before they are 35, the risk is completely eliminated. On the other hand, quitting between ages 45-54 still reduces the risk by a significant 78%, while doing so between ages 55-64 cuts it by 56%.

 

The research team found that similarly, the age of smoking initiation also has an impact on cancer risk. People who started smoking before age 18 had at least three times the risk of dying from cancer, while those who started before age 10 had four times the risk.

 

Tobacco use behavior following a cancer diagnosis

 

Another recent study published in Annals of Internal Medicine, found that quitting smoking following a lung cancer diagnosis may prevent cancer recurrence and extend life. Titled, “Postdiagnosis Smoking Cessation and Reduced Risk for Lung Cancer Progression and Mortality,” the study was conducted by researchers from the International Agency for Research on Cancer, the specialized cancer agency of the World Health Organization, in collaboration with the N.N. Blokhin National Medical Research Centre of Oncology in Russia. The research team recruited 517 current adults who were current smokers when they were diagnosed with early-stage non-small cell lung cancer from 2 sites in Moscow, Russia.

 

At the start of the study the participants were interviewed to determine medical and lifestyle history, including tumor characteristics, and their tobacco use patterns. Each participant was followed each year for an average of 7 years in a bid to record any changes in their smoking behavior.

 

Of 517 lung cancer patients who were smokers when diagnosed, less than half quit (44.5%), and very few relapsed. The patients who quit smoking were more likely to live longer overall (6.6 years vs. 4.8. years), live longer without lung cancer (5.7 vs. 3.9 years) and have their disease progress at a slower rate (7.9 vs. 6 years).

 

In light of these findings, the research team concluded that quitting smoking after being diagnosed with early-stage non-small cell lung cancer may slow disease progression and decrease mortality.

 

Source:VapingPost

Chelyabinsk Doctor Warns of E-Cigarette Dangers After Explosion Incident in Russia, No Injuries Reported
Chelyabinsk Doctor Warns of E-Cigarette Dangers After Explosion Incident in Russia, No Injuries Reported
Doctor Anton Ryzhiy warns of the dangers of e-cigarettes after explosion in Chelyabinsk, Russia, highlighting concerns for youth health.
Sep.17 by 2FIRSTS.ai
Company | Bloomberg: JTI Bets on Value Cigarettes Against the Tide, While Steadily Expanding Heated Tobacco Globally
Company | Bloomberg: JTI Bets on Value Cigarettes Against the Tide, While Steadily Expanding Heated Tobacco Globally
Bloomberg reports that Japan Tobacco International (JTI) is pursuing a strategy that contrasts with peers such as Philip Morris International (PMI) and British American Tobacco (BAT). While global tobacco majors push “smoke-free” transitions, JTI continues to cultivate combustible cigarettes—particularly value brands in the United States—while advancing the global rollout of its heated-tobacco brand Ploom. JTI forecasts that value-priced cigarettes will exceed a 40% share of the U.S. market by 2
Sep.28 by 2FIRSTS.ai
Ireland to Impose EU’s Highest Tax on Vape E-Liquids: €0.50 per ml, Effective Nov. 1
Ireland to Impose EU’s Highest Tax on Vape E-Liquids: €0.50 per ml, Effective Nov. 1
From Nov. 1, Ireland will levy €0.50/ml on all e-liquids and tighten rules—including a disposable ban; advocates warn this could hinder quitting amid a missed 2025 target.
Oct.21 by 2FIRSTS.ai
Mylor Innovation Lab Launches JuiSour Series: Revolutionizing Sour Aroma, Sour-Sweet Balance, and Juiciness in E-Liquids
Mylor Innovation Lab Launches JuiSour Series: Revolutionizing Sour Aroma, Sour-Sweet Balance, and Juiciness in E-Liquids
Mylor Innovation Lab will unveil its JuiSour Series at InterTabac in Dortmund, positioned around “aroma burst, sour-sweet balance,enhanced juiciness.” The new line comprises three sub-series — Berry, Candy, and Citrus — breaking through the limitations of traditional acetic acid and introducing the concept of a “Golden Sour-Sweet Ratio” to elevate the sour-aromatic profile and mouthfeel of e-liquids.
Sep.12
EU Cardiovascular Health Plan Consultation Highlights Tobacco Debate — 2Firsts Analysis Reveals Divide Between “Cessation” and “Harm Reduction” Approaches
EU Cardiovascular Health Plan Consultation Highlights Tobacco Debate — 2Firsts Analysis Reveals Divide Between “Cessation” and “Harm Reduction” Approaches
As the EU finalizes its Cardiovascular Health Plan, public feedback reveals a sharp divide over nicotine policy.A 2Firsts analysis of 677 submissions found that nearly one in four mentioned tobacco — highlighting tension between strict control and harm reduction approaches.
Oct.07
Product | HQD launches the new HQD GO in the U.S., featuring three power levels and a ~$30 price tag.
Product | HQD launches the new HQD GO in the U.S., featuring three power levels and a ~$30 price tag.
HQD has listed the disposable HQD GO on its official site and U.S. channels. The device touts 35,000 puffs, three power levels with adjustable airflow, and a 30 mg/ml nicotine strength. On U.S. retail websites, it’s priced at about $29.99.
Oct.24 by 2FIRSTS.ai